Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BON
stocks logo

BON

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Valuation Metrics

The current forward P/E ratio for Bon Natural Life Ltd (BON.O) is 0.00, compared to its 5-year average forward P/E of 5.04. For a more detailed relative valuation and DCF analysis to assess Bon Natural Life Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
5.04
Current PE
0.00
Overvalued PE
19.16
Undervalued PE
-9.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
1.68
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
4.07
Undervalued EV/EBITDA
-0.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.34
Current PS
0.00
Overvalued PS
0.74
Undervalued PS
-0.07
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

BON News & Events

Events Timeline

(ET)
2025-11-25
09:44:21
Bon Natural Life reveals $26M partnership deal with Beijing Huahai Keyuan
select
2025-09-09 (ET)
2025-09-09
08:33:15
Bon Natural Life Signs $18M Partnership Agreement in China
select
2025-08-05 (ET)
2025-08-05
09:04:34
Bon Natural Life receives compliance notification from Nasdaq
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
11-25Newsfilter
BON Partners with Huahai Keyuan for $26 Million Digestive Health Product Agreement
  • Cooperation Agreement Signed: BON has entered into a 36-month non-exclusive cooperation agreement with Huahai Keyuan, valued at $26 million, aimed at promoting the sales and distribution of its second-generation tea pigment-based digestive health products in Greater China.
  • Significant Market Potential: As a next-generation functional tea ingredient, tea pigments are projected to exceed a $1 billion market opportunity, primarily driven by the rapidly growing segments of digestive wellness and blood-glucose management, indicating strong consumer demand trends.
  • Enhanced Product Efficacy: BON's optimized fermentation process has resulted in over a 200% increase in the digestive health activity of its second-generation tea pigment product, significantly enhancing product efficacy and strengthening the company's competitive positioning in the market.
  • Strategic Development Phase: CEO Hu Yongwei stated that this partnership will accelerate BON's expansion into the premium digestive health market, with expectations of meaningful revenue and earnings growth, further enhancing long-term shareholder value.
[object Object]
Preview
7.5
11-25PRnewswire
BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan

  • Cooperation Agreement: Bon Natural Life Limited has entered a 36-month non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. to distribute its second-generation tea pigment-based digestive health products in Greater China, valued at US$26 million.

  • Innovative Product Development: BON has enhanced the digestive health benefits of its tea pigments by over 200% through a controlled biotransformation process, positioning the product as a significant advancement in the market.

  • Market Potential: The tea pigments are expected to tap into a market opportunity exceeding US$1 billion, driven by growing consumer demand in digestive wellness and blood-glucose management.

  • Strategic Growth Plans: CEO Hu Yongwei emphasized that this partnership will accelerate BON's expansion into the premium digestive health market and support long-term revenue and earnings growth.

[object Object]
Preview
9.0
09-02Newsfilter
BON Unveils Discovery of Potential Weight-Management Compounds from Tea Using AI-Driven Drug Development Platform

  • Breakthrough in Weight Management: Bon Natural Life Limited has identified a new class of natural polyphenolic compounds from tea that show significant potential for weight management, outperforming existing drugs in preliminary tests, thanks to its AI-powered R&D platform.

  • Market Growth Potential: The global weight-managing product market is projected to grow from USD 423.27 billion in 2024 to USD 601.26 billion by 2029, driven by rising obesity rates and increased awareness of healthy weight management, positioning BON to capture a significant market share with its new drug development.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Bon Natural Life Ltd (BON) stock price today?

The current price of BON is 1.8 USD — it has increased 0.56 % in the last trading day.

arrow icon

What is Bon Natural Life Ltd (BON)'s business?

Bon Natural Life Ltd is a China-based company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

arrow icon

What is the price predicton of BON Stock?

Wall Street analysts forecast BON stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BON is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Bon Natural Life Ltd (BON)'s revenue for the last quarter?

Bon Natural Life Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Bon Natural Life Ltd (BON)'s earnings per share (EPS) for the last quarter?

Bon Natural Life Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Bon Natural Life Ltd (BON)'s fundamentals?

The market is revising No Change the revenue expectations for BON for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 18.42%.
arrow icon

How many employees does Bon Natural Life Ltd (BON). have?

Bon Natural Life Ltd (BON) has 97 emplpoyees as of December 05 2025.

arrow icon

What is Bon Natural Life Ltd (BON) market cap?

Today BON has the market capitalization of 14.63M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free